Valuation Stratec SE Deutsche Boerse AG
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.27 EUR | +3.81% |
|
+4.74% | -18.19% |
| 07-03 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg gives a Buy rating | ZD |
| 05-12 | Stratec SE, Q1 2026 Earnings Call, May 11, 2026 |
Company Valuation: Stratec SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,669 | 983.7 | 553.7 | 362.2 | 272.9 | 221.2 | - | - |
| Change | - | -41.06% | -43.71% | -34.58% | -24.66% | -18.93% | - | - |
| Enterprise Value (EV) 1 | 1,705 | 983.7 | 520.2 | 451.5 | 385.4 | 321.8 | 318.9 | 316.9 |
| Change | - | -42.32% | -47.12% | -13.2% | -14.65% | -16.49% | -0.9% | -0.63% |
| P/E | 42x | 33.8x | 42.6x | 22.6x | -1,123x | 17.7x | 12.1x | 10.7x |
| PBR | 8.12x | - | 2.37x | 1.49x | 1.15x | 0.91x | 0.88x | 0.83x |
| PEG | - | -1.3x | -0.8x | 1x | 11x | -0x | 0.3x | 0.8x |
| Capitalization / Revenue | 5.81x | 3.58x | 2.11x | 1.41x | 1.09x | 0.83x | 0.78x | 0.74x |
| EV / Revenue | 5.94x | 3.58x | 1.99x | 1.75x | 1.54x | 1.2x | 1.12x | 1.07x |
| EV / EBITDA | 25.6x | 16.8x | 12.5x | 9.17x | 9.48x | 7.67x | 6.62x | 6.08x |
| EV / EBIT | 31.4x | 21.8x | 19.2x | 13.5x | 15.3x | 12.8x | 10.4x | 8.88x |
| EV / FCF | 39.4x | - | 46.9x | 11.6x | -23.1x | 13.5x | 17.3x | 19.8x |
| FCF Yield | 2.54% | - | 2.13% | 8.6% | -4.32% | 7.41% | 5.77% | 5.05% |
| Dividend per Share 2 | 0.952 | - | 0.55 | 0.6 | 0.6 | 0.6708 | 0.7724 | 0.8587 |
| Rate of return | 0.69% | - | 1.21% | 2.01% | 2.67% | 3.69% | 4.24% | 4.72% |
| EPS 2 | 3.28 | 2.4 | 1.07 | 1.32 | -0.02 | 1.029 | 1.508 | 1.707 |
| Distribution rate | 29% | - | 51.4% | 45.5% | -3,000% | 65.2% | 51.2% | 50.3% |
| Net sales 1 | 287.3 | 274.6 | 261.9 | 257.6 | 250.9 | 267.1 | 283.9 | 297.5 |
| EBITDA 1 | 66.61 | 58.58 | 41.58 | 49.21 | 40.64 | 41.93 | 48.14 | 52.11 |
| EBIT 1 | 54.27 | 45.05 | 27.07 | 33.46 | 25.17 | 25.12 | 30.73 | 35.68 |
| Net income 1 | 39.96 | 29.22 | 13.07 | 16.02 | -0.242 | 14.02 | 18.29 | 20.05 |
| Net Debt 1 | 36.57 | - | -33.53 | 89.25 | 112.5 | 100.6 | 97.7 | 95.69 |
| Reference price 2 | 137.80 | 81.10 | 45.55 | 29.80 | 22.45 | 18.20 | 18.20 | 18.20 |
| Nbr of stocks (in thousands) | 12,111 | 12,130 | 12,156 | 12,156 | 12,156 | 12,156 | - | - |
| Announcement Date | 3/30/22 | 3/28/23 | 3/28/24 | 5/19/25 | 4/28/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 26.21x | 4.72x | 18.18x | 0.35% | 195B | |
| 46.78x | 12.28x | 27.48x | -.--% | 151B | |
| 31.53x | - | - | 0.72% | 140B | |
| 16.58x | 3.44x | 11.09x | -.--% | 67.09B | |
| 33.65x | 7.54x | 23.96x | -.--% | 54.34B | |
| 18.43x | 2.12x | 10.92x | 2.85% | 44.63B | |
| 45.97x | 6.41x | 19.61x | -.--% | 37.24B | |
| 25.39x | 5.06x | 17.51x | 0.79% | 36.91B | |
| 19.78x | 5.2x | 13.42x | 1.16% | 30.24B | |
| Average | 29.37x | 5.85x | 17.77x | 0.65% | 83.99B | |
| Weighted average by Cap. | 31.20x | 6.64x | 19.48x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SBS Stock
- SBS Stock
- Valuation Stratec SE
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
